This issue of IOVS presents a novel strategy to develop treatment for nonexudative age-related macular degeneration (dry AMD) that derives from the natural, protective response of RPE cells to cellular stress. Oxidative stress is implicated in AMD pathogenesis and results in the upregulation of small heat shock proteins that act as molecular chaperones to prevent cellular apoptosis and minimize misfolded peptide reactivity. The a-crystallin family of heat shock proteins is associated with drusen formation and dry AMD. Proteomic analysis shows aB-crystallin to be a major protein constituent of AMD-associated drusen 1 and aB-crystallin is overexpressed specifically in RPE cells localized over drusen.
